Zdrowie i gospodarka · 16/12/2021

FDA Classifies Traumatic Brain Injury Eye Movement Assessment Aid as Class II Device with Special Controls

The FDA has classified the traumatic brain injury eye movement assessment aid as a Class II device with special controls, aiming to ensure its safety and effectiveness while enhancing patients' access to innovative devices.